Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/panel-backs-market-say-in-drug-prices-17323/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/panel-backs-market-say-in-drug-prices-17323/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/panel-backs-market-say-in-drug-prices-17323/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/panel-backs-market-say-in-drug-prices-17323/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-trace').style.display = (document.getElementById('cakeErr67f2702991a5b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2702991a5b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-code').style.display = (document.getElementById('cakeErr67f2702991a5b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-context').style.display = (document.getElementById('cakeErr67f2702991a5b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2702991a5b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2702991a5b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17195,
		&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17323,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17195,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17195,
	&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17323,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17195
$metaTitle = &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/panel-backs-market-say-in-drug-prices-17323.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Panel backs market say in drug prices | Im4change.org</title>
    <meta name="description" content="
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Panel backs market say in drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph<br /><br />A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br /><br />The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br /><br />The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br /><br />&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br /><br />However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br /><br />Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br /><br />A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br /><br />&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br /><br />&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br /><br />In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br /><br />&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br /><br />Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br /><br />Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-trace').style.display = (document.getElementById('cakeErr67f2702991a5b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2702991a5b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-code').style.display = (document.getElementById('cakeErr67f2702991a5b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-context').style.display = (document.getElementById('cakeErr67f2702991a5b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2702991a5b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2702991a5b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17195,
		&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17323,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17195,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17195,
	&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17323,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17195
$metaTitle = &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/panel-backs-market-say-in-drug-prices-17323.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Panel backs market say in drug prices | Im4change.org</title>
    <meta name="description" content="
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Panel backs market say in drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph<br /><br />A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br /><br />The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br /><br />The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br /><br />&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br /><br />However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br /><br />Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br /><br />A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br /><br />&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br /><br />&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br /><br />In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br /><br />&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br /><br />Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br /><br />Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-trace').style.display = (document.getElementById('cakeErr67f2702991a5b-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2702991a5b-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-code').style.display = (document.getElementById('cakeErr67f2702991a5b-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2702991a5b-context').style.display = (document.getElementById('cakeErr67f2702991a5b-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2702991a5b-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2702991a5b-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17195,
		&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17323,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17195,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17195,
	&#039;title&#039; =&gt; &#039;Panel backs market say in drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph&lt;br /&gt;
&lt;br /&gt;
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;
&lt;br /&gt;
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;
&lt;br /&gt;
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;
&lt;br /&gt;
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;
&lt;br /&gt;
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;
&lt;br /&gt;
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;
&lt;br /&gt;
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;panel-backs-market-say-in-drug-prices-17323&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17323,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17195
$metaTitle = &#039;LATEST NEWS UPDATES | Panel backs market say in drug prices&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;br /&gt;&lt;br /&gt;A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.&lt;br /&gt;&lt;br /&gt;The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &amp;mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.&lt;br /&gt;&lt;br /&gt;The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&amp;rdquo; Jena said.&lt;br /&gt;&lt;br /&gt;However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.&lt;br /&gt;&lt;br /&gt;Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.&lt;br /&gt;&lt;br /&gt;A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&amp;rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is because the more expensive brands of medicines also have the highest market shares.&amp;rdquo;&lt;br /&gt;&lt;br /&gt;In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &amp;mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This will only legitimise the rampant overpricing of drugs by companies,&amp;rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &amp;mdash; from 100 per cent to 5,600 per cent &amp;mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.&lt;br /&gt;&lt;br /&gt;Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.&lt;br /&gt;&lt;br /&gt;Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &amp;ldquo;We will send it in a week&amp;rsquo;s time,&amp;rdquo; Pawar said.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/panel-backs-market-say-in-drug-prices-17323.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Panel backs market say in drug prices | Im4change.org</title>
    <meta name="description" content="
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Panel backs market say in drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph<br /><br />A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br /><br />The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br /><br />The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br /><br />&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br /><br />However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br /><br />Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br /><br />A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br /><br />&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br /><br />&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br /><br />In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br /><br />&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br /><br />Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br /><br />Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 17195,
		'title' => 'Panel backs market say in drug prices',
		'subheading' => '',
		'description' => '<div align="justify">
-The Telegraph<br />
<br />
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br />
<br />
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br />
<br />
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br />
<br />
&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br />
<br />
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br />
<br />
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br />
<br />
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br />
<br />
&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br />
<br />
&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br />
<br />
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br />
<br />
&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br />
<br />
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br />
<br />
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.
</div>',
		'credit_writer' => 'The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'panel-backs-market-say-in-drug-prices-17323',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 17323,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 17195,
	'metaTitle' => 'LATEST NEWS UPDATES | Panel backs market say in drug prices',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...',
	'disp' => '<div align="justify">-The Telegraph<br /><br />A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br /><br />The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br /><br />The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br /><br />&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br /><br />However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br /><br />Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br /><br />A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br /><br />&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br /><br />&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br /><br />In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br /><br />&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br /><br />Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br /><br />Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 17195,
	'title' => 'Panel backs market say in drug prices',
	'subheading' => '',
	'description' => '<div align="justify">
-The Telegraph<br />
<br />
A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br />
<br />
The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br />
<br />
The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br />
<br />
&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br />
<br />
However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br />
<br />
Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br />
<br />
A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br />
<br />
&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br />
<br />
&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br />
<br />
In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br />
<br />
&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br />
<br />
Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br />
<br />
Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.
</div>',
	'credit_writer' => 'The Telegraph, 28 September, 2012, http://www.telegraphindia.com/1120928/jsp/nation/story_16028024.jsp#.UGUk0a55ykw',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'panel-backs-market-say-in-drug-prices-17323',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 17323,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 17195
$metaTitle = 'LATEST NEWS UPDATES | Panel backs market say in drug prices'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Telegraph

A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.

The policy finalised by the group of ministers...'
$disp = '<div align="justify">-The Telegraph<br /><br />A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines.<br /><br />The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments &mdash; from painkillers and antibiotics to asthma medications and drugs against high blood pressure.<br /><br />The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member.<br /><br />&ldquo;There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,&rdquo; Jena said.<br /><br />However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy.<br /><br />Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production.<br /><br />A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers.<br /><br />&ldquo;The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,&rdquo; Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph.<br /><br />&ldquo;This is because the more expensive brands of medicines also have the highest market shares.&rdquo;<br /><br />In the weighted average policy, weights are assigned to prices according to the share of a brand in the market &mdash; the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures.<br /><br />&ldquo;This will only legitimise the rampant overpricing of drugs by companies,&rdquo; the JSA said in a statement. Public health experts say the wide price differences of drugs &mdash; from 100 per cent to 5,600 per cent &mdash; suggest the prices of brands fixed by companies do not always reflect the actual cost of production.<br /><br />Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India.<br /><br />Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. &ldquo;We will send it in a week&rsquo;s time,&rdquo; Pawar said.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Panel backs market say in drug prices

-The Telegraph A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines. The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments — from painkillers and antibiotics to asthma medications and drugs against high blood pressure. The GoM has picked an option under which the maximum price of a medicine would be determined by the weighted average price of all its brands that have a market share of more than one per cent, said chemicals and fertiliser minister Srikant Jena, a GoM member. “There were three or four options in front of the GoM, but I think a broad agreement has been made on the option of one per cent market share,” Jena said. However, GoM sources said a pricing policy proposed by health minister Ghulam Nabi Azad, also a GoM member, had been rejected in favour of the market-based policy. Senior health ministry officials and public health experts have long been arguing for a drug pricing policy determined by the actual cost of production. A cost-based pricing policy determines prices by taking into account the costs of the raw materials needed to manufacture the drug, as well as the costs of marketing, distribution and retail commission, and allowing reasonable profits for the manufacturers. “The weighted average pricing policy adopted will skew prices in favour of higher priced medicines,” Amit Sengupta, a physician and convener of the Jan Swasthya Abhiyan (JSA), a network of non-government public health groups, told The Telegraph. “This is because the more expensive brands of medicines also have the highest market shares.” In the weighted average policy, weights are assigned to prices according to the share of a brand in the market — the maximum price at which a medicine can be sold will then be influenced more by brands with large market shares than those with lower figures. “This will only legitimise the rampant overpricing of drugs by companies,” the JSA said in a statement. Public health experts say the wide price differences of drugs — from 100 per cent to 5,600 per cent — suggest the prices of brands fixed by companies do not always reflect the actual cost of production. Expensive brands often have large market shares because their manufacturers typically promote such brands through high levels of incentives to doctors and retail chemists, said Sakthivel Selvaraj, a health economist with the Public Health Foundation of India. Agriculture minister Pawar told reporters that the policy would now go to the cabinet for a final view. “We will send it in a week’s time,” Pawar said.